Form 4: Reneo Pharmaceuticals Insider Buys Shares

Braden Michael Leonard, a director and 10% owner of Reneo Pharmaceuticals, acquired additional shares of the company's common stock through BML Investment Partners, L.P.

Summary

• On September 24, 2024, Braden Michael Leonard, a director and 10% owner of Reneo Pharmaceuticals, indirectly acquired 29,600 shares of common stock at a weighted average price of $1.4144.
• These shares were purchased through BML Investment Partners, L.P.
• Following this transaction, Mr. Leonard indirectly beneficially owned 3,388,649 shares.
• On September 25, 2024, Mr. Leonard indirectly acquired an additional 68,746 shares of common stock at a weighted average price of $1.4964.
• Following this transaction, Mr. Leonard indirectly beneficially owned 3,457,395 shares.
• Mr. Leonard also directly owns 1,020,769 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports insider buying activity. It doesn't express any opinion on the company's prospects.

Positives

• Insider buying can sometimes be seen as a positive signal, indicating that a director believes the company's stock is undervalued.

Industry Context

Insider trading activity is closely monitored by investors as it can provide insights into a company's prospects, although it is not always indicative of future performance.

Key Dates